Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 434

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 434
---
 and the Company’s convertible notes.
Such transactions collectively are referred to as the “PIPE Financing.”

<div align='center'>F-68

300,000 Shares of Common Stock

2,251,020 Pre-Funded Warrants to Purchase 2,251,020 Shares of Common Stock

2,551,020 Common Warrants to Purchase 2,551,020 Shares of Common Stock

4,802,040 Shares of Common Stock Issuable Upon Exercise of Pre-Funded Warrants and Common Warrants

CERO THERAPEUTICS HOLDINGS, INC.

PROSPECTUS

February 5, 2025

Sole Placement Agent

A.G.P.</div>